Vertex Pharmaceuticals offers promising opportunities in pain management, cystic fibrosis treatments, and a diversified ...

Clover Flex Sihuan Pharmaceutical's exclusive agent for botulinum toxin Letibao is approved for marketing by NMPA Vertex's Kalydeco for cystic fibrosis is close to approval in the EU Two imported new ...

INR:6560. blackjack real Bayer acquires AskBio for $4 billion to expand cell and gene therapy pipeline Vertex's Kalydeco for cystic fibrosis is close to approval i ...

INR:8074. france vs austria betting tips Science: There is scientific evidence that staying up late makes you stupid!

The top 10 pharmaceutical stocks are released! Hengrui Medicine aims to hit a market value of 370 billion yuan ASH | BTK inhibitor development trends: Eli Lilly, BeiGene, and AZ announce clinical resu ...

Nature: Large-scale screening discovered 21 existing anti-new coronavirus drugs! Sanofi expands collaboration with US$2.3 billion to develop mRNA vaccines for infectious diseases! Vertex's Kalydeco fo ...

INR:3725. across the unlverse fiona apple Will the next round of centralized procurement include Caronin, Enbipu, and Shupushen? "Fake stock" ST K ...

INR:6273. lakshmi lottery GSK's two-drug HIV therapy to receive priority review The first peanut allergy immunotherapy! Aimmune's desensitization therapy Palforzi ...

INR:2758. baran bet Yiling Pharmaceutical's Anastrozole Tablets Included in Priority Review Process The new medical insurance policy benefits 300 million people: more t ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.

Researchers at National Jewish Health and colleagues have completed the first study comparing lung macrophages in multiple ...